Raymonde M. Busch

Saarbruecken, SL, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Electromagnetic levitation containerless processing of metallic materials in microgravity: thermophysical properties.

Electromagnetic levitation containerless processing of metallic materials in microgravity: thermophysical properties.

Journal: NPJ microgravity
Published: August 19, 2022

Wave-Vector Dependence of the Dynamics in Supercooled Metallic Liquids.

Wave-Vector Dependence of the Dynamics in Supercooled Metallic Liquids.

Journal: Physical review letters
Published: March 02, 2020

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial.

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial.

Journal: Leukemia
Published: June 12, 2019

Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.

Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.

Journal: Leukemia
Published: January 05, 2019

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group.

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group.

Journal: Leukemia
Published: August 15, 2017

Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.

Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.

Journal: European journal of haematology
Published: November 02, 2016

FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia.

FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma
Published: July 01, 2016

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.

Journal: The Lancet. Oncology
Published: January 18, 2016

Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group.

Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group.

Journal: Leukemia & lymphoma
Published: August 22, 2015

Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.

Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.

Journal: American journal of hematology
Published: September 02, 2014

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia.

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia.

Journal: Blood
Published: June 12, 2014

Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.

Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.

Journal: Blood
Published: May 07, 2014
Showing 1-12 of 28

Last Updated: 09/26/2026